Inovio Pharmaceuticals, Inc.
- INO
- NASDAQ
- Biotechnology
- DNA-based Immunotherapy
- Vaccines/Infectious Disease
$0.99
Today −4.80%Quote Oct 16, 2026, 08:00 PM UTC
−18.17%over the last month
Max drawdown −23.6%From 1-month high −23.2%3 months −9.2%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$102.4M
Quote Oct 16
Next earnings
Nov 10
Expected, not confirmed
Analyst target
$2.75
+177.7% from here
Floor
$0.95
4.1% below price
Where the price sits
17 analysts
Analyst range, low to high
$2.50$3.00
- Price $0.99
- Resistance $1.00
- Consensus $2.75
The price is right under resistance. Analysts' average target sits about 178% higher.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about INOPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
112